Treatment

Pfizer’s Advanced Breast Cancer Drug Ibrance Approved for Sale

The U.S. federal health regulators have given accelerated approval for Pfizer Inc.’s Ibrance to treat advanced breast cancer.

New test could detect breast cancer signs in just three hours

A blood test that can detect early signs of breast cancer within three hours is to be launched in Britain next year, offering an alternative to X-ray mammograms.